CN104710483B - 一种硫酸氨基葡萄糖的制备方法 - Google Patents
一种硫酸氨基葡萄糖的制备方法 Download PDFInfo
- Publication number
- CN104710483B CN104710483B CN201410458623.3A CN201410458623A CN104710483B CN 104710483 B CN104710483 B CN 104710483B CN 201410458623 A CN201410458623 A CN 201410458623A CN 104710483 B CN104710483 B CN 104710483B
- Authority
- CN
- China
- Prior art keywords
- glucosamine
- solution
- added
- preparation
- sulphate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- CVCQAQVBOPNTFI-AAONGDSNSA-N (3r,4r,5s,6r)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol;sulfuric acid Chemical compound OS(O)(=O)=O.N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O.N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O CVCQAQVBOPNTFI-AAONGDSNSA-N 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims abstract description 44
- MSWZFWKMSRAUBD-UHFFFAOYSA-N 2-Amino-2-Deoxy-Hexose Chemical compound NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims abstract description 37
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Natural products CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 32
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims abstract description 24
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims abstract description 17
- 235000019441 ethanol Nutrition 0.000 claims abstract description 17
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000007787 solid Substances 0.000 claims abstract description 14
- MSWZFWKMSRAUBD-QZABAPFNSA-N beta-D-glucosamine Chemical compound N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-QZABAPFNSA-N 0.000 claims abstract description 13
- 150000003839 salts Chemical class 0.000 claims abstract description 10
- 239000002904 solvent Substances 0.000 claims abstract description 10
- 230000001476 alcoholic effect Effects 0.000 claims abstract description 9
- 238000005406 washing Methods 0.000 claims abstract description 5
- 125000005909 ethyl alcohol group Chemical group 0.000 claims abstract description 4
- 239000003960 organic solvent Substances 0.000 claims abstract description 4
- 238000007670 refining Methods 0.000 claims abstract description 3
- 238000000926 separation method Methods 0.000 claims abstract description 3
- 238000006243 chemical reaction Methods 0.000 claims description 40
- 238000003756 stirring Methods 0.000 claims description 17
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000011261 inert gas Substances 0.000 claims description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- 239000001569 carbon dioxide Substances 0.000 claims description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 3
- -1 D-Glucosamine Hydrochloride Sodium Chemical compound 0.000 claims description 2
- 239000006185 dispersion Substances 0.000 claims description 2
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- 229940095054 ammoniac Drugs 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims 1
- 239000003513 alkali Substances 0.000 abstract description 8
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract description 7
- 229910052700 potassium Inorganic materials 0.000 abstract description 7
- 239000011591 potassium Substances 0.000 abstract description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract description 5
- 229910052708 sodium Inorganic materials 0.000 abstract description 5
- 239000011734 sodium Substances 0.000 abstract description 5
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 4
- 238000006386 neutralization reaction Methods 0.000 abstract 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- 238000000034 method Methods 0.000 description 19
- 229960002442 glucosamine Drugs 0.000 description 13
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 12
- 238000001914 filtration Methods 0.000 description 8
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 7
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 7
- 229910001414 potassium ion Inorganic materials 0.000 description 7
- 229910001415 sodium ion Inorganic materials 0.000 description 7
- 238000007654 immersion Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- USDAQJSRGJCNNX-JJKGCWMISA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanamide;sulfuric acid Chemical compound OS(O)(=O)=O.NC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO USDAQJSRGJCNNX-JJKGCWMISA-N 0.000 description 5
- 239000001117 sulphuric acid Substances 0.000 description 5
- 235000011149 sulphuric acid Nutrition 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- CHVZQMAANSUXJU-JJKGCWMISA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanamide;hydrochloride Chemical compound Cl.NC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO CHVZQMAANSUXJU-JJKGCWMISA-N 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- UOVHNSMBKKMHHP-UHFFFAOYSA-L potassium;sodium;sulfate Chemical compound [Na+].[K+].[O-]S([O-])(=O)=O UOVHNSMBKKMHHP-UHFFFAOYSA-L 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 208000002682 Hyperkalemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 150000004263 amino monosaccharides Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 150000002301 glucosamine derivatives Chemical class 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 238000001728 nano-filtration Methods 0.000 description 1
- 208000009928 nephrosis Diseases 0.000 description 1
- 231100001027 nephrosis Toxicity 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
项目 | 实施例1 | 实施例2 | 实施例3 | 实施例4 | 实施例5 | 实施例6 |
性状 | 白色粉末 | 白色粉末 | 白色粉末 | 白色粉末 | 白色粉末 | 白色粉末 |
比旋度 | +56.6° | +56.6° | +56.6° | +56.6° | +56.6° | +56.6° |
干燥失重 | 0.20% | 0.28% | 0.16% | 0.12% | 0.25% | 0.38% |
重金属 | ≤10ppm | ≤10ppm | ≤10ppm | ≤10ppm | ≤10ppm | ≤10ppm |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410458623.3A CN104710483B (zh) | 2014-09-11 | 2014-09-11 | 一种硫酸氨基葡萄糖的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410458623.3A CN104710483B (zh) | 2014-09-11 | 2014-09-11 | 一种硫酸氨基葡萄糖的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104710483A CN104710483A (zh) | 2015-06-17 |
CN104710483B true CN104710483B (zh) | 2018-12-07 |
Family
ID=53410260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410458623.3A Active CN104710483B (zh) | 2014-09-11 | 2014-09-11 | 一种硫酸氨基葡萄糖的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104710483B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106008614A (zh) * | 2016-05-24 | 2016-10-12 | 天津青松华药医药有限公司 | 一种高纯度氨基糖类化合物的制备方法 |
CN106117276B (zh) * | 2016-06-27 | 2018-11-30 | 山东润德生物科技有限公司 | 一种硫酸氨基葡萄糖的制备方法 |
CN110734465B (zh) * | 2019-11-08 | 2021-05-28 | 山东润德生物科技有限公司 | 一种氨基葡萄糖硫酸钾盐的制备方法 |
CN110903330A (zh) * | 2019-12-23 | 2020-03-24 | 中研信谊(北京)医药科技有限公司 | 一种硫酸氨基葡萄糖氯化钠复盐的合成方法 |
CN112279878A (zh) * | 2020-12-08 | 2021-01-29 | 山东润德生物科技有限公司 | 一种制备高纯度氨基葡萄糖硫酸钾的方法及其应用 |
CN112679565A (zh) * | 2020-12-24 | 2021-04-20 | 山东润德生物科技有限公司 | 一种硫酸氨基葡萄糖的制备工艺 |
CN114853826A (zh) * | 2022-05-12 | 2022-08-05 | 山西辅仁恒峰药业有限公司 | 一种硫酸氨基葡萄糖氯化钠复盐制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101012251A (zh) * | 2007-01-11 | 2007-08-08 | 庄建华 | 一种硫酸氨基葡萄糖复合盐的制备方法 |
CN101830939A (zh) * | 2010-05-19 | 2010-09-15 | 王松叶 | 高纯d-氨基葡萄糖硫酸盐的制备方法 |
CN102850411A (zh) * | 2012-10-12 | 2013-01-02 | 江苏澳新生物工程有限公司 | 一种d-氨基葡萄糖硫酸氯化钾盐的制备方法 |
CN102850412A (zh) * | 2012-10-12 | 2013-01-02 | 江苏澳新生物工程有限公司 | 一种d-氨基葡萄糖硫酸氯化钠盐的制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2190379B1 (es) * | 2001-12-21 | 2004-11-16 | Bioiberica,S.A | Procedimiento de preparacion de sales de glucosamina. |
JP2004359908A (ja) * | 2003-06-06 | 2004-12-24 | Fuso Chemical Co Ltd | 精製グルコサミン塩及びその製造方法 |
CN102321124A (zh) * | 2011-09-07 | 2012-01-18 | 湖北爱普生物工程有限公司 | 一种制备硫酸氨基葡萄糖的新方法 |
CN103374044A (zh) * | 2012-04-16 | 2013-10-30 | 扬州鸿信生物制品有限公司 | 一种制备氨基葡萄糖硫酸盐的方法 |
CN103665056A (zh) * | 2012-09-03 | 2014-03-26 | 张娅 | 一种氨基葡萄糖硫酸盐的制备方法 |
-
2014
- 2014-09-11 CN CN201410458623.3A patent/CN104710483B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101012251A (zh) * | 2007-01-11 | 2007-08-08 | 庄建华 | 一种硫酸氨基葡萄糖复合盐的制备方法 |
CN101830939A (zh) * | 2010-05-19 | 2010-09-15 | 王松叶 | 高纯d-氨基葡萄糖硫酸盐的制备方法 |
CN102850411A (zh) * | 2012-10-12 | 2013-01-02 | 江苏澳新生物工程有限公司 | 一种d-氨基葡萄糖硫酸氯化钾盐的制备方法 |
CN102850412A (zh) * | 2012-10-12 | 2013-01-02 | 江苏澳新生物工程有限公司 | 一种d-氨基葡萄糖硫酸氯化钠盐的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104710483A (zh) | 2015-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104710483B (zh) | 一种硫酸氨基葡萄糖的制备方法 | |
CN101486669B (zh) | 一种合成牛磺酸的方法 | |
CN111646881B (zh) | 一种间三氟甲基苯酚的合成方法 | |
US10793512B2 (en) | Preparation method for high purity racemic adrenaline | |
CN105130854A (zh) | 一种改进的h酸生产工艺 | |
CN104557597B (zh) | 一种3‑(n,n‑二取代)氨基乙酰苯胺类化合物的清洁生产方法 | |
CN101830818A (zh) | 一种无水甜菜碱的制备方法 | |
CN106631852A (zh) | 一种从l‑鸟氨酸发酵液中提取l‑鸟氨酸盐酸盐的方法 | |
CN103554303A (zh) | 一种纯化羧甲基壳聚糖的方法 | |
CN101407478A (zh) | 肌酸盐酸盐的制备方法 | |
CN104231016A (zh) | 一种硫酸依替米星的制备方法 | |
CN101426795B (zh) | 制备多佐胺的方法 | |
US8680329B2 (en) | Process for preparation of α-ketoglutaric acid | |
US20120095204A1 (en) | Method to prepare d-glucosamine hydrochloride | |
CA2779168A1 (en) | Process for preparing a mixed salt of glucosamine sulfate and an alkali metal chloride | |
CN110668977B (zh) | 一种月桂酰精氨酸乙酯盐酸盐的制备工艺 | |
CN103420826A (zh) | 从发酵液中提取丁二酸的方法 | |
CN109970543B (zh) | 阿昔洛韦缩合副产物与溶剂回收利用的方法 | |
CN104355990B (zh) | 一种d-乙酯生产中回收和套用l-(+)-酒石酸的方法 | |
CN104193065A (zh) | 一种含有荧光增白剂废水的处理方法 | |
CN111217760B (zh) | 一种磺胺氯吡嗪钠的合成方法 | |
CN108752224B (zh) | 一种醋酸赖氨酸原料药的制备方法 | |
CN101033202A (zh) | 有机酸类稳定剂及其过碳酰胺的制备 | |
CN110372528B (zh) | 一种缬氨酸的提纯方法 | |
CN101450959A (zh) | 一种泰乐菌素的提取方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191106 Address after: 264205 No. 1 South Qingdao Road, Weihai economic and Technological Development Zone, Shandong, China Co-patentee after: Dijia Pharmaceutical Group Co.,Ltd. Patentee after: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Address before: 264205 No. 1 South Qingdao Road, Weihai economic and Technological Development Zone, Shandong, China Patentee before: DISHA PHARMACEUTICAL GROUP Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210422 Address after: 264205 middle section of Yinqiao street, Rushan Binhai New Area, Weihai City, Shandong Province Patentee after: Dishafimia Health Industry Co.,Ltd. Patentee after: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Patentee after: Dijia Pharmaceutical Group Co.,Ltd. Address before: 264205 No. 1 South Qingdao Road, Weihai economic and Technological Development Zone, Shandong, China Patentee before: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Patentee before: Dijia Pharmaceutical Group Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210624 Address after: 264205 middle section of Yinqiao street, Rushan Binhai New Area, Weihai City, Shandong Province Patentee after: Dishafimia Health Industry Co.,Ltd. Patentee after: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Address before: 264205 middle section of Yinqiao street, Rushan Binhai New Area, Weihai City, Shandong Province Patentee before: Dishafimia Health Industry Co.,Ltd. Patentee before: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Patentee before: Dijia Pharmaceutical Group Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211019 Address after: 264205 268 Tianrun Road, Wendeng economic and Technological Development Zone, Weihai, Shandong Patentee after: Dijia Pharmaceutical Group Co.,Ltd. Address before: 264205 middle section of Yinqiao street, Rushan Binhai New Area, Weihai City, Shandong Province Patentee before: Dishafimia Health Industry Co.,Ltd. Patentee before: DISHA PHARMACEUTICAL GROUP Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: No. 268, Tianrun Road, Wendeng Economic and Technological Development Zone, Weihai City, Shandong Province, 264200 Patentee after: Dijia Pharmaceutical Group Co.,Ltd. Address before: 264205 268 Tianrun Road, Wendeng economic and Technological Development Zone, Weihai, Shandong Patentee before: Dijia Pharmaceutical Group Co.,Ltd. |
|
CP03 | Change of name, title or address |